-+ 0.00%
-+ 0.00%
-+ 0.00%

KYVERNA THERAPEUTICS - KYSA-6 PHASE 3 GMG TRIAL ENROLLMENT ON TRACK FOR COMPLETION IN MID-2027

Reuters·11/12/2026 13:00:06

Please log in to view news